Intelligent Financial Strategies’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1K Hold
273
0.01% 53
2026
Q1
$23.3K Hold
273
0.01% 54
2025
Q4
$21.6K Hold
273
0.01% 64
2025
Q3
$21.9K Hold
273
0.01% 64
2025
Q2
$24.9K Hold
273
0.01% 71
2025
Q1
$25.6K Hold
273
0.01% 69
2024
Q4
$24.9K Hold
273
0.01% 68
2024
Q3
$28.4K Hold
273
0.02% 70
2024
Q2
$26.5K Hold
273
0.02% 70
2024
Q1
$24.6K Hold
273
0.02% 77
2023
Q4
$21.8K Hold
273
0.02% 72
2023
Q3
$19.4K Hold
273
0.01% 82
2023
Q2
$21.1K Hold
273
0.02% 82
2023
Q1
$20.6K Hold
273
0.02% 84
2022
Q4
$21.5K Buy
+273
New +$20.5K 0.02% 84
2022
Q3
Sell
-250
Closed -$20K 93
2022
Q2
$20K Sell
250
-965
-79% -$75.5K 0.02% 84
2022
Q1
$92K Sell
1,215
-423
-26% -$33.5K 0.09% 56
2021
Q4
$140K Buy
+1,638
New +$128K 0.13% 54

Other funds holding CL

Intelligent Financial Strategies's CL Position: Q2 2026 in Review

Intelligent Financial Strategies held its Colgate-Palmolive (CL) position steady in Q2 2026 at 273 shares worth $25.1K. The position accounts for 0.01% of the portfolio, ranked #53.

Intelligent Financial Strategies first reported a position in CL in Q4 2021 and has held it in 18 quarters since. The position peaked at $140K in Q4 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Intelligent Financial Strategies held 273 shares of Colgate-Palmolive worth $25.1K as of Q2 2026.
  • Intelligent Financial Strategies left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Intelligent Financial Strategies's portfolio in Q2 2026, its #53 holding.
  • Intelligent Financial Strategies first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • Intelligent Financial Strategies's Colgate-Palmolive position peaked at $140K in Q4 2021.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Intelligent Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.